NP673965.RASDuCKxkgmGFRmuSywLJbcxUKpPsPHvRggY-Ah xqUiw
has assertion: NP673965.RASDuCKxkgmGFRmuSywLJbcxUKpPsPHvRggY-Ah xqUiw130 assertion
has provenance: NP673965.RASDuCKxkgmGFRmuSywLJbcxUKpPsPHvRggY-Ah xqUiw130 provenance
has publication info: NP673965.RASDuCKxkgmGFRmuSywLJbcxUKpPsPHvRggY-Ah xqUiw130 publicationInfo
type: Nanopublication
created: 2014-10-02T12:38:47+02:00
rights: http://opendatacommons.org/licenses/odbl/1.0/
rights holder: IBIGroup
subject: SIO_000983
used data: disgenetrdf
authored by: http://orcid.org/0000-0001-5999-6269
authored by: http://orcid.org/0000-0002-7534-7661
authored by: 0000-0002-9383-528X
authored by: http://orcid.org/0000-0003-0169-8159
authored by: http://orcid.org/0000-0003-1244-7654
created by: http://orcid.org/0000-0003-0169-8159
version: v2.1.0.0

NP673965.RASDuCKxkgmGFRmuSywLJbcxUKpPsPHvRggY-Ah xqUiw130 assertion
type: Assertion
description: [The high event-free survival rates of Down syndrome (DS) children with acute myeloid leukemia (AML) are due, in part, to increased in vitro sensitivity of DS myeloblasts to cytosine arabinoside (ara-C) and daunorubicin and the greater generation of ara-C triphosphate (ara-CTP) from ara-C compared with myeloblasts from non-DS patients (Taub et al, Blood 87:3395, 1996).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
evidence: DisGeNET evidence - LITERATURE
SIO_000772: http://identifiers.org/pubmed/10438727
was generated by: ECO_0000203

befree-20140225
imported on: 2014-02-25

DisGeNET evidence - LITERATURE
type: ECO_0000212
comment: Gene-disease associations inferred from text-mining the literature.

disgenetrdf
version: v2.1.0